Filana Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Filana Therapeutics, Inc. (FLNA) had Deferred Tax Assets, Operating Loss Carryforwards of $78.63 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $78.63M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $43.15M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $33.32M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $28.02M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $78.63M 10-K · filed 2026-03-12 |
| 2024-12-31 | $43.15M 10-K · filed 2026-03-12 |
| 2023-12-31 | $33.32M 10-K · filed 2025-03-03 |
| 2022-12-31 | $28.02M 10-K · filed 2024-02-28 |
| 2021-12-31 | $24.78M 10-K · filed 2023-02-28 |
| 2020-12-31 | $18.33M 10-K · filed 2022-03-01 |
| 2019-12-31 | $17.11M 10-K · filed 2021-03-23 |
| 2018-12-31 | $16.50M 10-K · filed 2020-03-26 |
| 2017-12-31 | $15.60M 10-K · filed 2019-03-29 |
| 2016-12-31 | $22.30M 10-K · filed 2018-02-06 |
| 2015-12-31 | $17.10M 10-K · filed 2017-03-07 |
| 2014-12-31 | $13.80M 10-K · filed 2016-03-03 |
| 2013-12-31 | $10.20M 10-K · filed 2015-02-18 |
| 2012-12-31 | $9.20M 10-K · filed 2014-02-05 |
| 2011-12-31 | $6.50M 10-K · filed 2014-02-05 |
| 2010-12-31 | $3.00M 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |